menu
Showcases Stock ranks

Canopy Growth Corp (CGC)
14.59 -0.57 (-3.76%) 03-27 16:02
Open: 14.8 Pre. Close: 15.16
High: 15.99 Low: 14.435
Volume: 7,989,067 Market Cap: 4972M
Canopy Growth Corporation, together with its subsidiaries, engages in engages in production, distribution, and sale of cannabis in Canada. It operates through two segments, Cannabis Operations and Canopy Rivers. The company's products include dried flowers, oils and concentrates, softgel capsules, and hemps. It offers its products under the Tweed, Spectrum, DNA Genetics, CraftGrow, Tokyo Smoke, DOJA, Van der Pop, and Maitri brands. The company also provides growth capital and a strategic support platform that pursues investment opportunities in the global cannabis sector. Canopy Growth Corporation has a clinical research partnership with NEEKA Health Canada to investigate the efficacy of cannabinoids for the treatment of post-concussion neurological diseases in former NHL players; partnership with Parent Action on Drugs; and a collaboration with Cure Pharmaceutical Holding Corp. for the development of low-dose cannabidiol oral thin films. The company was formerly known as Twe
Share on Facebook   Tweet this page
Price Prediction (Update @5:00pm)
If tomorrow: Open lower Open higher
High: 16.003 - 16.084 16.084 - 16.136
Low: 14.261 - 14.361 14.361 - 14.424
Close: 14.437 - 14.587 14.587 - 14.684
Stock Technical Analysis
Overall:     
Target: Six months: 19.28
One year: 24.70
Support: Support1: 9.00
Support2: 7.49
Resistance: Resistance1: 16.51
Resistance2: 21.15
Pivot: 12.32
Moving Averages: MA(5): 13.84
MA(20): 13.53
MA(100): 19.00
MA(250): 28.37
MACD: MACD(12,26): -1.40
Signal(12,26,9): -2.00
%K %D: %K(14,3): 72.00
%D(3): 59.27
RSI: RSI(14): 48.54
52-Week: High: 52.74
Low: 9
Change(%): -65.7
Average Vol(K): 3-Month: 822656
10-Days: 760588
Price, MAs and Bollinger Bands
Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.

CGC has closed below upper band by 16.6%. Bollinger Bands are 9.4% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
Stock chart
Stock News
2020-03-29
Coronavirus Market Meltdown: Buy Canopy Growth Stock for Defensive Pot Status
Canopy Growth could enjoy some defensive stock status if the marijuana industry proves its mettle during the coronavirus demand disturbances. The post Coronavirus Market Meltdown: Buy Canopy Growth Stock for Defensive Pot Status appeared first on The Motley Fool Canada .

2020-03-28
The Week In Cannabis: Marijuana Stocks Outperform S&P Again As Weed Is Deemed 'Essential' In COVID-19 Times
As the coronavirus (COVID-19) pandemic continues to spread, more and more states in the U.S. decide to declare cannabis an “essential” good, just like basic groceries and traditional pharmaceutical medications. Interestingly, a majority of Americans seem to agree with these decisions. Most Americans (53%) believe medical marijuana dispensaries should be considered essential services. Democrats (62%) are more likely than Independents (52%) and Republicans (43%) to say this. Subscribe to YouGov Daily for more daily top-line data: https://t.co/9Q2fWMVkxo pic.twitter.com/rsWLKuPMQn — YouGovUS (@YouGovUS) March 25, 2020 But, while states are being pretty weed-friendly, the federal government maintains its anti-pot stance, excluding marijuana companies from its $2 trillion economic stimulus bill – which did include hemp. David Culver, VP of Government Relations at Canopy Growth Corp (NYSE: CGC ) commented on the issue, arguing “cannabis companies need and deserve the same economic relief extended to other industries.” Now, despite the lack of federal support, cannabis companies have been thriving in recent weeks, with most stocks up considerably, as sales hit record highs amid the coronavirus outbreak.

Financial Analysis
Growth NA
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability NA
Profitability measures a company's ability to generate earnings as compared to its expenses and other relevant costs.
Solvency NA
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency NA
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Stock Basics & Statistics
Exchange:  NYSE
Sector:  Healthcare
Industry:  Drug Manufacturers - Specialty Generic
Shares Out. (M) 348.33
Shares Float (M) 218.79
% Held by Insiders
% Held by Institutions
Shares Short (K) 45300
Shares Short Prior Month (K)
Stock Financials
EPS -1.790
Book Value (p.s.) 5.280
PEG Ratio
Profit Margin
Operating Margin
Return on Assets (ttm) -7.5
Return on Equity (ttm) -51.0
Qtrly Rev. Growth 228.4
Gross Profit (p.s.) 0.255
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth
Operating Cash Flow (M)
Levered Free Cash Flow (M)
Stock Valuation
P/E -8.15
P/E Growth Ratio -0.04
P/BV 2.76
P/S
P/CF
Dividend Yield
Dividends & Splits
Dividend
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010

Stoxline Lite

Stoxline Pro

Stock Chart

Option Calculator